Scarica l'app Stockscreener
0.6901
0.09%
0.0006
Dopo l'orario di chiusura:
.68
-0.0101
-1.46%
Precedente Chiudi:
$0.6895
Aprire:
$0.69
Volume 24 ore:
326.57K
Relative Volume:
0.30
Capitalizzazione di mercato:
$35.73M
Reddito:
-
Utile/perdita netta:
$-81.22M
Rapporto P/E:
-0.2331
EPS:
-2.96
Flusso di cassa netto:
$-74.41M
1 W Prestazione:
-4.81%
1M Prestazione:
+4.50%
6M Prestazione:
-15.85%
1 anno Prestazione:
-26.21%
Intervallo 1D:
$0.6801
$0.6962
Intervallo di 1 settimana:
$0.6619
$0.75
Portata 52W:
$0.62
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
Nome
Xilio Therapeutics Inc
Settore
Industria
Telefono
617-833-1027
Indirizzo
828 WINTER STREET, WALTHAM
Confronta XLO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.6901 | 35.70M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-21 | Iniziato | Chardan Capital Markets | Buy |
| 2022-01-10 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-16 | Iniziato | Cowen | Outperform |
| 2021-11-16 | Iniziato | Guggenheim | Buy |
| 2021-11-16 | Iniziato | Morgan Stanley | Overweight |
| 2021-11-16 | Iniziato | Raymond James | Outperform |
Mostra tutto
Xilio Therapeutics Inc Borsa (XLO) Ultime notizie
Does Xilio Therapeutics Inc. stock pay reliable dividendsRecord-breaking gains - jammulinksnews.com
What risks could impact Xilio Therapeutics Inc. stock performanceDouble-digit growth - jammulinksnews.com
What makes Xilio Therapeutics Inc. stock attractive to long term investorsRapid wealth accumulation - jammulinksnews.com
What analysts say about Xilio Therapeutics Inc. stockExplosive market performance - Autocar Professional
Xilio Therapeutics Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional
Is Xilio Therapeutics Inc. a good long term investmentOverwhelming profit margins - jammulinksnews.com
What drives Xilio Therapeutics Inc. stock priceHigh-return market picks - jammulinksnews.com
What makes Xilio Therapeutics Inc. stock price move sharplyFree Best Stocks to Buy Today - Newser
What analysts say about Xilio Therapeutics Inc. stock outlookFree Step-by-Step Investment Guide - Newser
Why Xilio Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser
How Xilio Therapeutics Inc. stock performs during market volatilityFree Deep Market Trend Analysis - Newser
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Xilio Therapeutics Awards $7,400 in Stock Options to Strategic New Employees - Stock Titan
Xilio Therapeutics Executives Increase Holdings - TradingView
Xilio Therapeutics, Inc. (NASDAQ:XLO) Short Interest Update - Defense World
Xilio Therapeutics Expands Authorized Shares at Annual Meeting - TipRanks
Xilio Therapeutics Appoints Akintunde Bello to Board of Directors - citybiz
Xilio Therapeutics appoints oncology veteran Akintunde Bello to board By Investing.com - Investing.com South Africa
Xilio Therapeutics expands board, elects new director - Investing.com Australia
Xilio Therapeutics expands board, elects new director By Investing.com - Investing.com South Africa
Xilio Therapeutics Inc Azioni (XLO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):